{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:12:34Z","timestamp":1772017954962,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:00:00Z","timestamp":1439424000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"McNeil Consumer Healthcare"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s40261-015-0311-9","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T11:23:53Z","timestamp":1439378633000},"page":"547-558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pharmacokinetics, Safety, and Cardiovascular Tolerability of Phenylephrine\u00a0HCl 10, 20, and 30\u00a0mg After a Single Oral Administration in Healthy Volunteers"],"prefix":"10.1007","volume":"35","author":[{"given":"Cathy K.","family":"Gelotte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda A.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,13]]},"reference":[{"key":"311_CR1","doi-asserted-by":"crossref","first-page":"110S","DOI":"10.1002\/j.1875-9114.1993.tb02779.x","volume":"13","author":"DA Johnson","year":"1993","unstructured":"Johnson DA, Hrick JG. The pharmacology of a-adrenergic decongestants. Pharmacotherapy. 1993;13:110S\u20135S.","journal-title":"Pharmacotherapy"},{"key":"311_CR2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2165\/00003495-198121060-00003","volume":"21","author":"DW Empey","year":"1981","unstructured":"Empey DW, Medder KT. Nasal decongestants. Drugs. 1981;21:438\u201343.","journal-title":"Drugs"},{"key":"311_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF03259892","volume":"3","author":"SS Chua","year":"1988","unstructured":"Chua SS, Benriomj SI. Non-prescription sympathomimetic agents and hypertension. Med Toxicol. 1988;3:387\u2013417.","journal-title":"Med Toxicol"},{"key":"311_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI101270","volume":"21","author":"A Keys","year":"1942","unstructured":"Keys A, Violante A. The cardio-circulatory effects in man of neo-synephrin. J Clin Invest. 1942;21:1\u201312.","journal-title":"J Clin Invest."},{"key":"311_CR5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00637623","volume":"21","author":"JH Hengstmann","year":"1982","unstructured":"Hengstmann JH, Goronzy J. Pharmacokinetics of 3H-phenylephrine in man. Eur J Clin Pharmacol. 1982;21:335\u201341.","journal-title":"Eur J Clin Pharmacol"},{"key":"311_CR6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jchromb.2007.09.011","volume":"858","author":"P Ptacek","year":"2007","unstructured":"Ptacek P, Macek JK. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of phenylephrine in human plasma and its application to a pharmacokinetic study. J Chromatogr B. 2007;858:263\u20138.","journal-title":"J Chromatogr B"},{"key":"311_CR7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00228-014-1788-5","volume":"71","author":"HC Atkinson","year":"2015","unstructured":"Atkinson HC, Stanescu I, Salem II, Potts AL, Anderson BJ. Increased bioavailability of phenylephrine by co-administration of acetaminophen: results of four open-label, crossover pharmacokinetic trials in healthy volunteers. Eur J Clin Pharmacol. 2015;71:151\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"311_CR8","unstructured":"Method P898. Quantitation of unconjugated phenylephrine in human plasma via HPLC with MS\/MS detection, Issued 2009. Middleton: PPD Bioanalytical Laboratory; 2009."},{"key":"311_CR9","unstructured":"Method P956. Quantitation of phenylephrine and phenylephrine glucuronide in human urine via HPLC with MS\/MS detection. Issued 2009. Middleton: PPD Bioanalytical Laboratory; 2009."},{"key":"311_CR10","unstructured":"Method P957. Quantitation of 3-hydroxymandelic acid in human urine via HPLC with MS\/MS detection. Issued 2009. Middleton: PPD Bioanalytical Laboratory; 2009."},{"key":"311_CR11","unstructured":"Method P958. Quantitation of total phenylephrine in human urine via HPLC with MS\/MS detection. Issued 2009. Middleton: PPD Bioanalytical Laboratory; 2009."},{"key":"311_CR12","first-page":"11","volume":"44","author":"A Dominguez-Rodriguez","year":"2009","unstructured":"Dominguez-Rodriguez A, Abreu-Gonzalez P, Kaskic J. Disruption of normal circadian rhythms and cardiovascular events. Heart Metab. 2009;44:11\u20135.","journal-title":"Heart Metab"},{"key":"311_CR13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2869.2007.00581.x","volume":"16","author":"G Vandewalle","year":"2007","unstructured":"Vandewalle G, Middleton B, Rajaratnam S, et al. Robust circadian rhythm in heart rate and its variability: influence of exogenous melatonin and photoperiod. J Sleep Res. 2007;16:148\u201355.","journal-title":"J Sleep Res"},{"key":"311_CR14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00228-006-0194-z","volume":"62","author":"RI Harris","year":"2006","unstructured":"Harris RI, Steare SE. A meta-analysis of ECG data from healthy male volunteers: diurnal and intra-subject variability, and implications for planning ECG assessments and statistical analysis in clinical pharmacology studies. Eur J Clin Pharmacol. 2006;62:893\u2013903.","journal-title":"Eur J Clin Pharmacol"},{"key":"311_CR15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0002-9149(92)90562-D","volume":"70","author":"A Sagie","year":"1992","unstructured":"Sagie A, Larson MG, Goldberg RJ, Bengston JR, Levy D. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol. 1992;70:797\u2013801.","journal-title":"Am J Cardiol"},{"key":"311_CR16","unstructured":"Guidance for Industry. E14 clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Rockville: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, ICH; 2005."},{"key":"311_CR17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/j.1550-8528.1997.tb00573.x","volume":"5","author":"D Nagy","year":"1997","unstructured":"Nagy D, DeMeersman R, Gallagher D, et al. QTc interval (cardiac repolarization): lengthening after meals. Obesity Res. 1997;5:531\u20137.","journal-title":"Obesity Res"},{"key":"311_CR18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s002280050682","volume":"55","author":"E Widerlov","year":"1999","unstructured":"Widerlov E, Jostell KG, Claesson L, et al. Influence of food intake on electrocardiograms of healthy male volunteers. Eur J Clin Pharmacol. 1999;55:619\u201324.","journal-title":"Eur J Clin Pharmacol"},{"key":"311_CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/009286150503900304","volume":"39","author":"Pharmaceutical Research and Manufacturers of America QT Statistics Expert Working Team","year":"2005","unstructured":"Pharmaceutical Research and Manufacturers of America QT Statistics Expert Working Team. Investigating drug-induced QT and QTc prolongation in the clinic: a review of statistical design and analysis considerations: report from the pharmaceutical research and manufacturers of America QT statistics expert team. Drug Inf J. 2005;39:243\u201366.","journal-title":"Drug Inf J"},{"key":"311_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.2042-7158.1983.tb04293.x","volume":"35","author":"KE Ibrahim","year":"1983","unstructured":"Ibrahim KE, Midgley JM, Crowley JR, Williams CM. The mammalian metabolism of R-(-)-m-synephrine. J Pharm Pharmacol. 1983;35:144\u20137.","journal-title":"J Pharm Pharmacol."},{"key":"311_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jelectrocard.2014.01.012","volume":"47","author":"PM Rautaharju","year":"2014","unstructured":"Rautaharju PM, Zhang ZM, Haisty WK, et al. Race- and sex-associated differences in rate-adjusted QT, QTpeak, ST elevation and other regional measures of repolarization: the Atherosclerosis Risk in Communities (ARIC) study. J Electrocardiol. 2014;47:342\u201350.","journal-title":"J Electrocardiol"},{"key":"311_CR22","unstructured":"Consumer Healthcare Products Association. Briefing book: meeting of the Nonprescription Drugs Advisory Committee, December 2007 [Docket no. 2007P-0047]. p. 40\u201345. http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/07\/briefing\/2007-4335b1-03-CHPA.pdf . Accessed 21 Apr 2015."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-015-0311-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0311-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-015-0311-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T14:00:32Z","timestamp":1718028032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-015-0311-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,13]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["311"],"URL":"https:\/\/doi.org\/10.1007\/s40261-015-0311-9","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,13]]}}}